CR2 and acute lymphoblastic leukemia: To confirm the hypothesis that copanlisib pretreatment may increase low CD21 expression above a threshold required for CAR-T efficacy, we identified a PDX T-ALL sample with very low CD21 density (PDX3, 207 ABC) and engrafted a further cohort of NSG mice.